Gilead Sciences

Use the CVFCC to evaluate whether the communication strategy was appropriate. How should Gilead use the CVFCC to adjust and communicate its strategy moving forward?

Case Study CASE: December 6, 2013, had the makings of a good day for Gilead Sciences, Inc. The United States Food and Drug Administration (FDA) had just approved Sovaldi,1 a hepatitis C treatment, after a wildly successful trial program that saw more than 90% of patients cured.2 In addition, the cost of the treatment would […]

Scroll to top